163 related articles for article (PubMed ID: 30776040)
21. Solubility enhancement of BCS Class II drug by solid phospholipid dispersions: Spray drying versus freeze-drying.
Fong SY; Ibisogly A; Bauer-Brandl A
Int J Pharm; 2015 Dec; 496(2):382-91. PubMed ID: 26468038
[TBL] [Abstract][Full Text] [Related]
22. Melt extrusion vs. spray drying: The effect of processing methods on crystalline content of naproxen-povidone formulations.
Haser A; Cao T; Lubach J; Listro T; Acquarulo L; Zhang F
Eur J Pharm Sci; 2017 May; 102():115-125. PubMed ID: 28259831
[TBL] [Abstract][Full Text] [Related]
23. Formulation and Scale-up of Delamanid Nanoparticles via Emulsification for Oral Tuberculosis Treatment.
Caggiano NJ; Armstrong MS; Georgiou JS; Rawal A; Wilson BK; White CE; Priestley RD; Prud'homme RK
Mol Pharm; 2023 Sep; 20(9):4546-4558. PubMed ID: 37578286
[TBL] [Abstract][Full Text] [Related]
24. Formulation design and evaluation of amorphous ABT-102 nanoparticles.
Jog R; Kumar S; Shen J; Jugade N; Tan DC; Gokhale R; Burgess DJ
Int J Pharm; 2016 Feb; 498(1-2):153-69. PubMed ID: 26705150
[TBL] [Abstract][Full Text] [Related]
25. Producing Amorphous Solid Dispersions via Co-Precipitation and Spray Drying: Impact to Physicochemical and Biopharmaceutical Properties.
Mann AKP; Schenck L; Koynov A; Rumondor ACF; Jin X; Marota M; Dalton C
J Pharm Sci; 2018 Jan; 107(1):183-191. PubMed ID: 28711592
[TBL] [Abstract][Full Text] [Related]
26. Systemic in vitro and in vivo evaluation for determining the feasibility of making an amorphous solid dispersion of a B-Raf (rapidly accelerated fibrosarcoma) inhibitor.
Cui Y; Chiang PC; Choo EF; Boggs J; Rudolph J; Grina J; Wenglowsky S; Ran Y
Int J Pharm; 2013 Sep; 454(1):241-8. PubMed ID: 23834830
[TBL] [Abstract][Full Text] [Related]
27. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
28. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
29. Preparation and evaluation of raloxifene-loaded solid dispersion nanoparticle by spray-drying technique without an organic solvent.
Tran TH; Poudel BK; Marasini N; Chi SC; Choi HG; Yong CS; Kim JO
Int J Pharm; 2013 Feb; 443(1-2):50-7. PubMed ID: 23318367
[TBL] [Abstract][Full Text] [Related]
30. Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals.
Zuo B; Sun Y; Li H; Liu X; Zhai Y; Sun J; He Z
Int J Pharm; 2013 Oct; 455(1-2):267-75. PubMed ID: 23876497
[TBL] [Abstract][Full Text] [Related]
31. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
32. Solid nanocrystalline dispersions of ziprasidone with enhanced bioavailability in the fasted state.
Thombre AG; Caldwell WB; Friesen DT; McCray SB; Sutton SC
Mol Pharm; 2012 Dec; 9(12):3526-34. PubMed ID: 23075293
[TBL] [Abstract][Full Text] [Related]
33. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
[TBL] [Abstract][Full Text] [Related]
34. Dissolution and precipitation behavior of ternary solid dispersions of ezetimibe in biorelevant media.
Alhayali A; Tavellin S; Velaga S
Drug Dev Ind Pharm; 2017 Jan; 43(1):79-88. PubMed ID: 27487184
[TBL] [Abstract][Full Text] [Related]
35. A comparative study of spray-dried and freeze-dried hydrocortisone/polyvinyl pyrrolidone solid dispersions.
Dontireddy R; Crean AM
Drug Dev Ind Pharm; 2011 Oct; 37(10):1141-9. PubMed ID: 21615280
[TBL] [Abstract][Full Text] [Related]
36. Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations.
Vogt M; Kunath K; Dressman JB
Eur J Pharm Biopharm; 2008 Feb; 68(2):283-8. PubMed ID: 17574403
[TBL] [Abstract][Full Text] [Related]
37. Hot Melt Extrusion and Spray Drying of Co-amorphous Indomethacin-Arginine With Polymers.
Lenz E; Löbmann K; Rades T; Knop K; Kleinebudde P
J Pharm Sci; 2017 Jan; 106(1):302-312. PubMed ID: 27817830
[TBL] [Abstract][Full Text] [Related]
38. Characterization of Amorphous and Co-Amorphous Simvastatin Formulations Prepared by Spray Drying.
Craye G; Löbmann K; Grohganz H; Rades T; Laitinen R
Molecules; 2015 Dec; 20(12):21532-48. PubMed ID: 26633346
[TBL] [Abstract][Full Text] [Related]
39. Characterisation of spray dried microencapsules with amorphous lutein nanoparticles: Enhancement of processability, dissolution rate, and storage stability.
Ding Z; Wang X; Wang L; Zhao Y; Liu M; Liu W; Han J; Prakash S; Wang Z
Food Chem; 2022 Jul; 383():132200. PubMed ID: 35168049
[TBL] [Abstract][Full Text] [Related]
40. A novel architecture for achieving high drug loading in amorphous spray dried dispersion tablets.
Mudie DM; Buchanan S; Stewart AM; Smith A; Shepard KB; Biswas N; Marshall D; Ekdahl A; Pluntze A; Craig CD; Morgen MM; Baumann JM; Vodak DT
Int J Pharm X; 2020 Dec; 2():100042. PubMed ID: 32154509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
